Thank you, Paul, and good afternoon, everyone. Having pre-announced select’s financial results for the third quarter last week, I will briefly review these metrics and provide more color on our performance and then turn attention to what we are doing to adjust our global operations to fit the current macroeconomic reality and business environment. We expected a modest return to growth in the third quarter of 2023, which did not materialize as category-specific and broader consumer headwinds continued and drove weaker-than-expected sales volumes, reduced promotional effectiveness and adverse changes in our product sales mix. Net revenues for the third quarter were $75.3 million, down approximately 9% year-over-year. In turn, lower volumes, coupled with higher levels of discounting and other factors, exerted significant downward pressure on our gross margin relative to our previous expectations, with gross profit swinging to a loss of approximately $7 million. This result obscured continuing progress we’re making on COGS reductions, where year-over-year, we reduced cost of goods sold by 18%. Despite these challenging circumstances, we were able to achieve free cash flow positive operations for the quarter. As we indicated when setting this goal 1 year ago, this outcome reflects a meaningful benefit from working capital as a source of cash. And while encouraging should not be interpreted to new that we have turned the corner to sustained free cash flow positive operations. We do however believe that is indicative of the early progress we are making in our objective to reduce cash consumption even as the company takes additional measures to substantially reduce OpEx, make changes to pricing architecture and further prioritize current growth opportunities. I will now dive into our strategy and plan to accelerate our transition to sustainable and ultimately profitable operations. We are pursuing five main actions to improve our cost structure and overall operating performance. One, as previously announced, we are executing a 19% reduction in our global non-production employee base, immediate step in a broader program to improve our cost structure; two, we are reviewing our pricing strategy with certain channels to support margin expansion; three, we are continuing to utilize inventory management to reduce working capital; four, we are intensifying our focus on channels and geographies that are exhibiting revenue growth; and five, in U.S. retail, we are using our portfolio and marketing to directly counter misinformation about our products and category. I will now provide further commentary in each of these five areas: operating expense reduction, a reduction in force combined with the elimination of certain open positions is expected to result in approximately $10.5 million to $12.5 million in operating expense savings in 2024 and is an immediate step in a broader cost-cutting initiative to better align our operating expenses with current revenue. While necessary, this is a difficult decision for the business given the tremendous talent, expertise and passion of our workforce. Our people are what make us special and letting these team members go is done with a very heavy heart. Though we reduced year-to-date operating expenses by 29% or $73.9 million year-over-year to further cut costs as we look to establish our operating expense base for 2024 at a level that better reflects current revenues, we are initiating a review of our global operations focused on narrowing our commercial focus to certain growth opportunities, and accelerating activities that prioritize gross margin expansion and cash generation. As part of these efforts, we are evaluating intend to reduce activities related to certain underperforming geographies, markets and channels, including a review and potential restructuring of our operations in China. We are further focusing our research and development to near-term product renovations and innovations and a more limited set of breakthrough projects and programs. As I will elaborate on momentarily, we are more narrowly deploying our marketing spend in the U.S. around the primary message of taste and health. More generally, we continue to invest focus and resources around lean management in support of overall expense reduction and margin expansion, including the potential exit of certain product lines and further optimization of our manufacturing capacity and real estate footprint to reduce overall complexity and drive additional cost savings relating to logistics, overhead, tolling and general production pricing architecture. As you know, over the last year, we have used pricing in an effort to bring new consumers into the category and to support our inventory reduction and cash generation objectives. While these pricing programs are effective in generating cash and inventory that did not help us move from early adopters to mainstream consumers. We believe there are likely several reasons for this outcome, among them, increased consumer confusion over our value proposition and the remaining price delta between Beyond Meat products and their animal protein equivalent. As we look to 2024, we expect to implement a more nuanced pricing strategy, keeping certain programs and pricing in place, while adjusting others in support of gross margin expansion. Inventory management, we intend to continue to manage inventory levels down to generate cash. We’ve made some progress in this regard as inventory levels have fallen by 21% year-over-year, yet we have many miles left to travel as we seek to bring inventory in line with lean management principles. Commercial focus on current growth markets and channels, we are encouraged by and are investing in markets and partnerships that are currently exhibiting growth. This includes select markets in Europe and in particular, certain strategic partners where we are experiencing year-over-year double-digit growth. Bidding back in U.S. retail, we are pursuing the portfolio and marketing approach intended to restore growth in U.S. retail. We are contending with two main headwinds. First, there are broader challenges facing the U.S. consumer, namely higher prices and reduced buying power. We believe that the corresponding consumer action of trading down among proteins that is foregoing more expensive cuts of animal meat for cheaper cuts of meat, similarly impacting our category and brand. We are, despite aforementioned pricing programs at certain exceptions, a higher-priced protein relative to animal protein. Second, as I previously mentioned, we continue to face serious category perception challenge. As I’ve long maintained as a brand and category, we will cross the chasm to mainstream on the strength of progress across taste, health and price and to a lesser extent here in the U.S., awareness of the planetary benefits of our products. We continue to make organoleptic progress across our portfolio, which the team is wrapping up recognition and awards as we close the century gap between our products and their animal protein equivalent. And it is, in our view, the health perception of the category that is the most immediate and important variable to address in order to restore growth. We must squarely and forcefully counter the broad misinformation that swirls around our category before we can more effectively use pricing as a tool to bring new users in the mainstream consumer into our category. There is a loud and steady drumbeat of advertisements, peds and social media post and activities that seek to negatively influence the consumer regarding our products and category. Generally, this always-on attack platform uses 1 or more of 3 million rhetorical anchors, sake meat, processed and full of chemicals. The financial backers of the successful campaign appear to range from more obvious, such as various members of the meat industry, the less obvious, which may include members of the pharmaceutical industry, the latter seeking to preserve one of the largest global markets for antibiotics, livestock. As you may know, it’s estimated that over 70% of medically important antibiotics are given not to humans, but to livestock. As I shared, this effort to sow doubt to confusion regarding our products has worked, while 50% of U.S. consumers believe that plant-based meats were healthy in 2020. By 2022, this number had declined at 38%, and my guess is that this percentage would be lower today. This well-orchestrated campaign borrows heavily from similar efforts to frustrate tobacco legislation and the tighter regulation of under-aged consumption of alcohol and, in fact, share some of the same players. We are confident that the strong health benefits available to consumers the use of our products will ultimately overcome these tactics. This said, we are not passively waiting and instead are taking the following actions. First, we continue to support third-party research regarding the health outcomes available to consumers through our products. This research includes our ongoing work with Stanford University School of Medicine, and a growing and formal consortium of universities, hospitals and institutions. We derive significant value from this research in at least 2 ways. First, we achieved and can share a more precise understanding of the impact of our products on key human health indices, for example, cholesterol levels. Second, we are surrounded by leading medical and nutritional experts who are instrumental in our efforts to, over time, deliver even greater health benefits in future iterations of our products. Second, we are teaming up with leading associations to validate and help familiarize the consumer with the health benefits of our products. These partnerships and affiliations include, as we’ve highlighted, the American Heart Association, which has recently expanded the number of Beyond products, earning its rigorous certification as a hard healthy food as well as our multiyear program with American Cancer Society to further research on plant-based meat and cancer prevention. In 2024, we expect to announce additional certifications and partnerships that we believe provide important third-party endorsements and/or recognition of the health benefits of our products. Third, to make accessible and amplify the positive health outcomes associated with our products. We are teaming up with authentic voices, including ambassadors, medical professionals and registered dietitian and nutritionist to counter false narratives and educate the consumer on the ingredients and process we use for our plant-based meats. There will be more to come on this front in the coming quarters, and we look forward to updating you on our progress accordingly. In closing, we are disappointed by our third quarter 2023 results and are taking immediate action to pull significant costs out of our operating base as we enter 2024. Simultaneously, we are heightening and narrowing our focus around specific geographies and channels where we are experiencing growth, including in the EU, where we’re seeing favorable near-term trends, such as certain segments of U.S. Foodservice. As we head into 2024, we believe we have a solid portfolio and marketing strategy to address category and brand headwinds in U.S. retail, one built around the fundamental benefits available to the consumer through our carefully designed plant-based meats. Though we believe that our achievement of cash flow positive operations for the third quarter is an encouraging directional signal, we are committed to a far more comprehensive and aggressive rebalancing of operating expense to current revenues as we plan for the future. We understand the current results, category challenges and the intended media coverage can distract from what we believe is a far brighter future. We see this future in colleges and universities here in the U.S. and abroad, including those where use-driven movements are calling for fully plant-based campuses to fight climate change, drawing analogies to university pledges to divest from fossil fuels. We see this future in countries where per capita animal meat consumption is the lowest ever in recorded history, such as in the UK and Germany and the corresponding progress we are experiencing in McDonald’s McPlant platform in these and other EU economies. We see this future in cities, such as Amsterdam, where officials are taking tangible steps to increase availability of plant-based meats and dairy in support of their target to have 50% of citizens consuming a plant-based diet by 2030. And in South Korea, where the Minister of Agriculture, Food and Rural Affairs recently announced strategic plan to support the growth and consumption of plant-based meats and alternative proteins. And we see this future in the use-driven petition to have the upcoming UN Climate Summit, top 28, the majority plant-based and a UN’s acknowledgment of the legitimacy and seaming [indiscernible] this demand. Finally, we see this future when together with the medical and nutrition community, we mobilized to push back against incumbent industry propaganda and put in place our strong response yet to this troubling misinformation campaign. In summary, though we did not foresee the current trough in our journey of disruption, we are confident in our ability to successfully fight through it, and fulfill our vision of being tomorrow’s global protein company of size and significance, a company dedicated to empowering consumers through delicious and satiating products to take meaningful action to address the urgent human health, climate natural resource and animal welfare challenges facing our global society. With that, I will turn it over to Lubi, our Chief Financial Officer and Treasurer, to walk us through our third quarter financial results in greater detail as well as update our outlook for 2023.